Chouihed, Tahar http://orcid.org/0000-0003-2486-3049
Rossignol, Patrick
Bassand, Adrien
Duarte, Kévin
Kobayashi, Masatake
Jaeger, Déborah
Sadoune, Sonia
Buessler, Aurélien
Nace, Lionel
Giacomin, Gaetan
Hutter, Thibaut
Barbé, Françoise
Salignac, Sylvain
Jay, Nicolas
Zannad, Faiez
Girerd, Nicolas
Funding for this research was provided by:
French National Research Agency Fighting Heart Failure (ANR-15-RHU-0004)
Article History
Received: 26 May 2018
Accepted: 18 October 2018
First Online: 28 October 2018
Compliance with ethical standards
:
: Dr Chouihed and Dr. Girerd have received board membership fees from Novartis. Dr. Rossignol received fees from Relypsa. Dr. Zannad has received fees for serving on the board of Boston Scientific; consulting fees from Novartis, Takeda, AstraZeneca, Boehringer Ingelheim, GE Healthcare, Relypsa, Servier, Boston Scientific, Bayer, Johnson and Johnson, and Resmed; and speakers’ fees from Pfizer and AstraZeneca. He and Dr. Rossignol are cofounders of CardioRenal diagnosticS.